BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Cosmos Holdings Announces Third Quarter 2017 Results

  Cosmos Holdings announced financial results for the quarter ended September 30, 2017.

  November 28, 2017

   · 

  2 min read
• Genetown

  Ivenix Demonstrates Infusion System With Enhanced Patient Safety at ASHP Meeting

  Attendees will have the opportunity to learn and engage at a booth presentation by Ivyruth Andreica, PharmD, BSN, FISMP, Clinical & Medication Safety Pharmacist for Ivenix.

  November 28, 2017

   · 

  3 min read
• Biotech Bay

  Bio-Rad Authorizes New $250M Share Repurchase Program

  Repurchases may be made at management’s discretion from time to time on the open market or through privately negotiated transactions.

  November 28, 2017

   · 

  4 min read
• 

  Drug Development

  Egalet Surges as Back Pain Drug Meets Goals in Phase III Trial

  The study met its primary endpoint, which showed a statistically significant difference in average pain intensity from baseline to week 16 between the Egalet-002 and placebo treatment groups.

  November 28, 2017

   · 

  6 min read
• Pharm Country

  Artemis Therapeutics Announces Issuance of European Patent for Artemisone for the Treatment of Viral Infections

  The European patent will provide intellectual property protection for the Artemisone program in key markets and is expected to expire no earlier than 2033.

  November 28, 2017

   · 

  3 min read
• Biotech Bay

  ITUS Receives Notice of Allowance for Second Key Cancer Technology Patent

  ITUS is developing a platform called Cchek from which it expects to launch a series of non-invasive, inexpensive diagnostic blood tests for early cancer detection.

  November 28, 2017

   · 

  4 min read
• Business

  Titan Pharmaceuticals Partners With Molteni to Market Probuphine in Europe

  Titan and Molteni expect to enter into the definitive license and distribution agreement during the first quarter of 2018.

  November 28, 2017

   · 

  5 min read
• Deals

  Sample6 Pathogen DETECT Platform Acquired by IEH

  This divestment allows Sample6 to focus exclusively on its groundbreaking and highly-regarded CONTROL food safety software.

  November 28, 2017

   · 

  2 min read
• 

  Biotech Bay

  Bay Area’s Qool Therapeutics Scores $8M for Targeted Temperature Management System

  The funding was provided by Zhongji Holdings LTD/Join Medical Technology, TAMCAP LLC, BrilliMedical International Corp., BioPacific Investors, Western Technology Investment, and FundRx.

  November 28, 2017

   · 

  3 min read
• Easton Pharma / Alliance Group Awaits Equipment Delivery, Days Away From Commencing Operations on its Aggregate Contract After Closing $1.3M JV Agreement for 50% Property Ownership Interest and Various Business

  Once delivered, operations will commence which should then allow for additional contracts currently under negotiations to close.

  November 28, 2017

   · 

  5 min read